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S U M M A R Y
Objective: To investigate the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) nasal
carriage in rural and urban community settings of Bolivia and Peru.
Methods: MRSA nasal carriage was investigated in 585 individuals living in rural and urban areas of
Bolivia and Peru (one urban area, one small rural village, and two native communities, one of which was
highly isolated). MRSA isolates were subjected to molecular analysis for the detection of virulence genes,
characterization of the staphylococcal cassette chromosome mec (SCCmec), and genotyping (multilocus
sequence typing (MLST) and pulsed-ﬁeld gel electrophoresis (PFGE)).
Results: An overall very low prevalence of MRSA nasal carriage was observed (0.5%), with MRSA carriers
being detected only in a small rural village of the Bolivian Chaco. The three MRSA isolates showed the
characteristics of community-associated MRSA (being susceptible to all non-beta-lactam antibiotics and
harboring the SCCmec type IV), were clonally related, and belonged to ST1649.
Conclusions: This study provides an insight into the epidemiology of MRSA in community settings of
Bolivia and Peru. Reliable, time-saving, and low-cost methods should be implemented to encourage
continued surveillance of MRSA dissemination in resource-limited countries.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Staphylococcus aureus can cause a wide range of human
diseases, being among the major human pathogens both in the
community and in the hospital setting.1 In fact, it is a leading cause
of complicated skin and soft tissue infections, as well as of serious
nosocomial infections, such as bloodstream infections, pneumonia,
and other bioﬁlm-associated difﬁcult-to-treat infections.1 S. aureus
is also a common colonizer of the human host and can be detected§ The results of this study were presented in part at the 49th Interscience
Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, USA,
September 12–15, 2009.
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http://dx.doi.org/10.1016/j.ijid.2012.11.017in the nares and at other body sites (e.g., pharynx, groin, axillae,
vagina, and gastrointestinal tract) in a large proportion of healthy
individuals (approximately 30%, with important differences in
carriage rates depending on the studied population).2 Colonization
is known to represent an important risk factor for infection.1,2
Over the past few decades, S. aureus has become an even greater
therapeutic challenge following the emergence of methicillin-
resistant S. aureus (MRSA) strains, which are resistant to all
available beta-lactams due to the production of the low afﬁnity
penicillin-binding protein PBP2a (encoded by the transferable
mecA gene).3 MRSA strains were conﬁned for a long time to
hospitals and other health care settings (hospital-associated MRSA,
HA-MRSA), but have recently also emerged as community-
associated pathogens (CA-MRSA), generating an additional public
health concern.3 Relatively few clonal lineages are responsible for
the majority of MRSA infections worldwide. In fact, evolutionaryses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Studied communities.
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mecA by already epidemic methicillin-susceptible S. aureus clones,
giving rise to ﬁve major pandemic lineages that have spread
globally (clonal complexes CC5, CC8, CC2, CC45, and CC30).4
Latin America is not an exception in the worldwide increasing
incidence of MRSA infections, although the molecular epidemiol-
ogy of MRSA clones in this area is still largely unknown, especially
in the community setting.5
Here we report the results of a study on the prevalence and
molecular epidemiology of MRSA nasal carriage in rural and urban
community settings of Bolivia and Peru.
2. Materials and methods
2.1. Study design and population
MRSA nasal carriage was investigated in 585 individuals living
in rural and urban areas of Bolivia and Peru (Figure 1). The study
was conducted in an urban area of Peru (Iquitos, Loreto
Department), in a small rural village of Bolivia (Gutierrez, Santa
Cruz Department), and in two native communities including a
Guaranı´ community located in the Bolivian Chaco (Javillo, Santa
Cruz Department) in regular contact with the village of Gutierrez,
and a very remote and highly isolated Chayahuita community in
the Peruvian Amazon forest (Angaiza, Loreto Department)
(Figure 1 and Table 1). In Iquitos and Gutierrez the studied
households were selected with a modiﬁed cluster sampling,6 andTable 1
Characteristics of the studied communities, sampling criteria, and prevalence of MRSA
Setting Type (population) Year 
Javillo, Bolivia Native community (ca. 100) 2008 
Gutierrez, Bolivia Rural village (ca. 700) 2009 
Iquitos, Peru Urban area (ca. 400 000) 2009 
Angaiza, Peru Remote native community (ca. 130) 2009 criteria for eligibility of individuals within each selected household
were the following: up to four individuals (two younger and two
older than 14 years) in Iquitos, and all available individuals in
Gutierrez (Table 1). In the native communities, all available
individuals were considered eligible for the study (Table 1). Prior to
enrollment, written informed consent was obtained from all adult
participants and from the parents or legal guardians of minors. Any
literate participant signed the consent form. In the case of an
illiterate participant, the consent form was read and signed by a
witness (who was present throughout the consent procedure and
interview) and marked by the participant/parent. The consent
procedure and interviews were always conducted by trained local
healthcare workers (with the help of a local translator in the native
communities). In each country, full ethical clearance was obtained
from the qualiﬁed authorities who had revised and approved the
study design (Convenio de Salud, Ministerio de Salud – Vicariato de
Camiri, Camiri, Bolivia; Comite´ Institucional de E´tica de la
Universidad Peruana Cayetano Heredia, Lima, Peru).
2.2. Screening for MRSA nasal carriage
For each individual included in the study, nasal swabs were
obtained from both nares (using a single swab); these were
preserved in Amies transport medium (Oxoid, Italy) and processed
within 4 days. Each swab was eluted in 0.5 ml of normal saline
(room temperature for 10 min), and 10 ml of the suspension were
plated onto mannitol salt agar (MSA), placing a cefoxitin disk nasal carriers
Sampling criterion Tested individuals Carriers, n (%)
All available individuals 64 0 (0)
Random sampling 196 3 (1.5)
Random sampling 200 0 (0)
All available individuals 125 0 (0)
Figure 2. PFGE patterns of the three MRSA isolates from Gutierrez, Bolivia. M,
ProMega-Markers Lambda Ladders (Promega, Madison, WI), with DNA size
standards indicated on the right in kilobase pairs.
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within the inhibition zone were subcultured onto MRSA chromo-
genic agar (Oxoid), and one colony of putative MRSA from each
sample was further studied. S. aureus species identiﬁcation was
conﬁrmed by detection of coagulase activity (using rabbit plasma),
by the Vitek-2 system (bioMe´rieux Inc., Marcy l’Etoile, France), and
by a PCR approach using primers targeting the eap gene.7
2.3. In vitro susceptibility testing
Antimicrobial susceptibility was determined by the disk
diffusion method, in accordance with the Clinical and Laboratory
Standards Institute (CLSI) guidelines.8,9 Antibiotics tested included
cefoxitin, penicillin G, erythromycin, clindamycin, tetracycline,
ciproﬂoxacin, trimethoprim–sulfamethoxazole, gentamicin, chlor-
amphenicol, and rifampin (Oxoid). Inducible clindamycin resis-
tance was investigated by the D-zone test, as per the CLSI
guidelines. S. aureus ATCC 25923 was used for quality control
purposes. Methicillin resistance was always conﬁrmed by ampli-
ﬁcation of the mecA gene, as described previously.10
2.4. Characterization of MRSA strains
All MRSA isolates were subjected to molecular analysis for the
detection of virulence genes, characterization of the staphylococcal
cassette chromosome mec (SCCmec), and genotyping.
Detection of the Panton–Valentine leukocidin (PVL) was
performed by PCR ampliﬁcation of the lukS-PV and lukF-PV genes,
as proposed by Lina et al.11 SCCmec typing (including subtyping of
SCCmec type IV) was performed by previously described multiplex
PCR approaches.10,12 Multilocus sequence typing (MLST) was
performed as described by Enright et al.,13 with analysis of
sequences held on the MLST website (http://www.mlst.net).
Pulsed-ﬁeld gel electrophoresis (PFGE) was carried out using the
standard US Centers for Disease Control and Prevention (CDC)
PulseNet protocol available from the CDC website (http://
www.cdc.gov/HAI/pdfs/labSettings/ar_mras_PFGE_s_aureus.pdf).
3. Results
3.1. Prevalence of MRSA nasal carriage
In the present study, an overall very low prevalence of MRSA
nasal carriage was observed among apparently healthy individuals
living in urban and rural settings of Bolivia and Peru (Table 1). In
fact, of the 585 individuals studied, only three (0.5%) were found to
be colonized by MRSA. MRSA carriers were only detected in the
small rural village of the Bolivian Chaco (three of 196 individuals
investigated, 1.5%), whilst carriage of MRSA was not observed in
the two native communities nor, quite unexpectedly, in the urban
area in Peru (Figure 1).
MRSA carriers from Gutierrez (aged 51, 11, and 11 years,
respectively) were found to belong to three different households,
and one of them reported hospitalization during the 12 months
preceding the study (an 11-year old child). Recent antibiotic use
(i.e., 2 weeks preceding the study) was excluded for all of them.
Other studied members of these three households (n = 10, 6, and 8,
respectively) tested negative for MRSA colonization, and none of
them reported a recent hospitalization.
3.2. Characterization of MRSA strains
The three MRSA isolates were found to be susceptible to other
antibiotics tested including erythromycin, clindamycin, tetracy-
cline, ciproﬂoxacin, trimethoprim–sulfamethoxazole, gentamicin,
chloramphenicol, and rifampin.Molecular analysis revealed that they belonged to ST1649 and
exhibited related PFGE proﬁles (i.e., two were identical and one
differed for 2 bands) (Figure 2). All harbored SCCmec type IV
(subtype c or e, as per the Milheiric¸o scheme)12 and were PVL-
negative.
4. Discussion
MRSA clones have emerged as a global public health concern
both in the hospital and in the community setting.1,3 Despite one of
the ﬁve major MRSA pandemic clones originating in Brazil (the so-
called Brazilian clone) and several epidemic MRSA clones having
spread through Latin America in the last two decades, data on the
molecular epidemiology of MRSA in this area remain limited,
especially those concerning the community setting.5
In the present study, we documented that nasal carriage of
MRSA among apparently healthy individuals from urban and rural
settings of Bolivia and Peru remains very low (range 0–1.5%). To
the best of our knowledge, this is the ﬁrst study on the prevalence
of MRSA nasal carriage in the community setting in these two Latin
American countries.
The three MRSA isolates detected in this study (all from the
small Bolivian village) showed the characteristics of CA-MRSA
(being susceptible to all non-beta-lactam antibiotics and harboring
the SCCmec type IV), were clonally related, and were assigned to
ST1649 (belonging to CC6). MRSA isolates belonging to ST1649 or
A. Bartoloni et al. / International Journal of Infectious Diseases 17 (2013) e339–e342e342CC6 have already been detected sporadically in nasal specimens
from healthy individuals in European countries.14,15
Efforts should be made to implement reliable, time-saving, and
low-cost methods for the detection of MRSA colonization in order
to encourage continued surveillance of MRSA dissemination in
resource-limited countries.
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